PARIS & NANTES, France--(BUSINESS WIRE)--Regulatory News: Servier, an independent global pharmaceutical group, and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) (Paris:OSE), a French ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback